{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:10:03Z","timestamp":1788988203866,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neurot.2026.e00946","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:50:43Z","timestamp":1782964243000},"page":"e00946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Yuye","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurot.2026.e00946_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00946_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1570159X14666151208112754","article-title":"Current treatment options for Alzheimer's disease and Parkinson's disease dementia","volume":"14","author":"Szeto","year":"2016","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00946_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8227(01)00266-2","article-title":"Dementia and its associations in type 2 diabetes mellitus: the Fremantle diabetes study","volume":"53","author":"Bruce","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00946_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4093\/dmj.2022.0209","article-title":"Renoprotective mechanism of sodium-glucose cotransporter 2 inhibitors: focusing on renal hemodynamics","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.neurot.2026.e00946_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221086996","article-title":"Sodium-glucose cotransporter 2 inhibitors and neurological disorders: a scoping review","volume":"13","author":"Tharmaraja","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.neurot.2026.e00946_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115755","article-title":"SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model","volume":"168","author":"Sim","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-020-00607-4","article-title":"Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes","volume":"12","author":"Hierro-Bujalance","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00946_bib10","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s10787-022-00973-5","article-title":"Dapagliflozin as an autophagic enhancer via LKB1\/AMPK\/SIRT1 pathway in ovariectomized\/D-galactose Alzheimer's rat model","volume":"30","author":"Ibrahim","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00946_bib11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-19-0259","article-title":"Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study","volume":"181","author":"Wium-Andersen","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00946_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3233\/JAD-215678","article-title":"Association between use of sodium-glucose Co-Transporter-2 (SGLT2) inhibitors and cognitive function in a longitudinal study of patients with type 2 diabetes","volume":"87","author":"Low","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00946_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc22-1705","article-title":"Association of sodium-glucose cotransporter 2 inhibitors with time to dementia: a population-based cohort study","volume":"46","author":"Wu","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00946_bib14","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/jgs.18306","article-title":"Newer glucose-lowering drugs and risk of dementia: a systematic review and meta-analysis of observational studies","volume":"71","author":"Tang","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00946_bib15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1177\/13872877241309674","article-title":"SGLT2 inhibition, circulating biomarkers, and Alzheimer's disease: a Mendelian randomization study","volume":"103","author":"Yang","year":"2025","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00946_bib16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s40265-019-01146-5","article-title":"Sotagliflozin: first global approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00946_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2017.11.114","article-title":"Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP\/PS1\/tau mouse model of Alzheimer's disease","volume":"495","author":"Cai","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"6824","key":"10.1016\/j.neurot.2026.e00946_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1515\/revneuro-2018-0008","article-title":"Role of p38\/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapy","volume":"30","author":"Kheiri","year":"2018","journal-title":"Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00946_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.neurot.2026.e00946_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1214301","article-title":"Research landscape and emerging trends of diabetes-associated cognitive dysfunction: a bibliometric analysis","volume":"17","author":"He","year":"2023","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00946_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00946_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00946_bib26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s41380-022-01878-z","article-title":"Neuroinflammation is independently associated with brain network dysfunction in Alzheimer's disease","volume":"28","author":"Leng","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00946_bib27","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2026.e00946_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00946_bib29","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1471-4159.2009.06537.x","article-title":"Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders","volume":"112","author":"von Bernhardi","year":"2010","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00946_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37887-3","article-title":"Extracellular tau stimulates phagocytosis of living neurons by activated microglia via toll-like 4 receptor-NLRP3 inflammasome-caspase-1 signalling axis","volume":"13","author":"Pampuscenko","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00946_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/glia.24160","article-title":"The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model","volume":"70","author":"Stancu","year":"2022","journal-title":"Glia"},{"issue":"33","key":"10.1016\/j.neurot.2026.e00946_bib32","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00946_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","article-title":"Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease","volume":"24","author":"Itagaki","year":"1989","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00946_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00946_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14409","article-title":"MKP-1 regulates the inflammatory activation of microglia against Alzheimer's disease","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00946_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030168","article-title":"Modulating neuroinflammation as a prospective therapeutic target in Alzheimer's disease","volume":"14","author":"Lee","year":"2025","journal-title":"Cells"},{"issue":"Pt A","key":"10.1016\/j.neurot.2026.e00946_bib37","article-title":"Resibufogenin, one of bufadienolides in toad venom, suppresses LPS-induced inflammation via inhibiting NF-\u03baB and AP-1 pathways","volume":"113","author":"Gao","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00946_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250056","article-title":"TLR4 phosphorylation at tyrosine 672 activates the ERK\/c-FOS signaling module for LPS-induced cytokine responses in macrophages","volume":"53","author":"Curson","year":"2023","journal-title":"Eur J Immunol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747926001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:39:51Z","timestamp":1788986391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747926001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1878747926001169"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00946","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00946"}}